首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

2126626

子宮內膜消融市場：按裝置類型、消融方法、最終用戶和地區分類

Endometrial Ablation Market, By Device Type, By Ablation Method, By End User, By Geography

出版日期: 2026年08月17日 | 出版商:

Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，子宮內膜消融術市場規模將達到 42.6 億美元，到 2033 年將達到 66.7 億美元。預計從 2026 年到 2033 年，該市場將以 6.6% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	42.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.60%	2033年市場規模預測：	66.7億美元

由於月經過多盛行率上升、人們對微創治療的偏好日益成長、對子宮內膜消融術的認知度提高以及消融設備的技術進步，預計市場將保持穩定成長。根據美國疾病管制與預防中心 (CDC) 統計，美國每年有超過 1,000 萬名女性患有月經過多，這凸顯了有效治療方法的必要性。

子宮內膜消融術是一種微創手術，透過破壞子宮內膜來減少月經過多。通常適用於藥物無法有效控制月經過多的女性。常用的消融技術包括射頻消融術、熱球消融術、熱液消融術、微波能消融術和冷凍消融術。

手術時間縮短、恢復期減少、門診婦科手術日益普及以及對子宮切除術替代方案的需求不斷成長，都進一步推動了市場成長。此外，射頻、熱消融和其他消融技術的不斷進步也為製造商創造了新的商機。監管部門的批准、產品改進、臨床試驗和策略合作預計也將在預測期內支持市場成長。

市場動態

子宮內膜消融術市場的發展受到以下因素的推動：月經過多帶來的負擔日益加重、人們對微創手術的偏好日益成長、對子宮保留療法的認知不斷提高以及消融設備的技術進步。

導致月經過多（月經量過多）盛行率上升是主要成長要素之一。月經過多會影響日常生活，並可能導致缺鐵性貧血。根據美國疾病管制與預防中心 (CDC) 統計，每年有超過 1,000 萬名美國女性患有月經過多，大量患者亟需有效治療。對於藥物治療效果不佳的女性，可考慮子宮內膜消融術。

推動市場成長的另一個主要因素是人們對微創治療的偏好日益成長。子宮內膜消融術無需切除子宮即可減少月經出血，通常可以在門診進行。與創傷性較大的手術相比，子宮內膜消融術治療和恢復時間更短，這提高了合格的患者和醫療專業人員對這種治療方式的興趣。

消融系統的技術進步進一步推動了市場擴張。射頻電極、熱球系統、熱流體技術、微波能和冷凍療法為控制性破壞子宮內膜提供了多種方法。特別是射頻系統，能夠實現快速治療和穩定的能量供應。臨床研究也證實了雙極射頻消融術具有良好的止血效果。

人們對子宮切除術替代方案的認知不斷提高，為市場創造了更多機會。子宮內膜消融術為月經過多的合適患者提供了一種保留子宮的治療選擇。患者和醫護人員對手術的認知不斷提高，加上門診婦科護理水準的提高，預計將加速該手術的普及。

然而，子宮內膜消融術市場面臨許多挑戰，例如先進消融設備高成本、手術適應症有限，以及藥物治療和子宮切除術等替代療法的存在。儘管存在這些挑戰，但持續的技術發展、對微創醫療日益成長的需求以及醫療投資的增加，預計將在預測期內為子宮內膜消融術市場創造成長機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
本研究深入分析了市場促進因素、限制因素、機會、市場趨勢、區域前景以及領先企業採取的競爭策略。
本研究根據公司亮點、產品系列、重大發展、財務表現和策略，對子宮內膜消融市場的主要參與者進行了概況介紹。
透過利用本報告中提出的見解，行銷負責人和經營團隊可以就產品開發、市場擴張和策略合作夥伴關係做出明智的決策。
子宮內膜消融市場報告的目標受群眾外包括子宮內膜消融設備製造商、婦科醫生、醫院、醫療保健提供者、經銷商、投資者、監管機構和行業分析師等各類相關人員。
相關人員可以利用用於評估子宮內膜消融市場的系統分析框架和策略矩陣，從中獲益匪淺。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- RF Medical
- Erbe Inc.
- MedGyn Inc.
- Ri.Mos. Inc.
- Biosense Webster Inc.
- Hansen Medical Inc.
- Biotronik
- Smith & Nephew plc
- Arthrex
- Wallach.

第9章

參考
調查方法

簡介目錄

Product Code: CMI1109

Endometrial Ablation Market is estimated to be valued at USD 4.26 Bn in 2026 and is expected to reach USD 6.67 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.6% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.26 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.60%	2033 Value Projection:	USD 6.67 Bn

The market is projected to witness steady growth owing to the rising prevalence of heavy menstrual bleeding, increasing preference for minimally invasive treatments, growing awareness of endometrial ablation, and technological advancements in ablation devices. According to the U.S. Centers for Disease Control and Prevention (CDC), heavy menstrual bleeding affects more than 10 million women in the U.S. each year, supporting the need for effective treatment options.

Endometrial ablation is a minimally invasive procedure that destroys the inner lining of the uterus to reduce heavy menstrual bleeding. It is generally considered for women whose heavy bleeding is not adequately controlled with medication. Common techniques include radiofrequency electrosurgery, thermal balloon ablation, heated fluid ablation, microwave energy ablation, and cryotherapy.

The market growth is further supported by shorter procedure times, reduced recovery periods, increasing adoption of outpatient gynecological procedures, and growing demand for alternatives to hysterectomy. In addition, continuous advancements in radiofrequency, thermal, and other ablation technologies are creating new opportunities for manufacturers. Regulatory approvals, product improvements, clinical studies, and strategic collaborations are also expected to support market growth during the forecast period.

Market Dynamics

The Endometrial Ablation Market is driven by the rising burden of heavy menstrual bleeding, growing preference for minimally invasive procedures, increasing awareness of uterine-sparing treatments, and technological advancements in ablation devices.

One of the primary growth drivers is the increasing prevalence of heavy menstrual bleeding. Heavy menstrual bleeding can affect daily activities and may contribute to iron-deficiency anemia. According to the CDC, more than 10 million American women experience heavy menstrual bleeding each year, creating a large patient population requiring effective treatment. Women whose symptoms are not adequately controlled with medication may be considered for endometrial ablation.

Another major factor driving market growth is the growing preference for minimally invasive treatment options. Endometrial ablation can reduce menstrual bleeding without removing the uterus and can often be performed as an outpatient procedure. Shorter treatment and recovery times compared with more invasive surgical procedures are increasing interest in ablation among suitable patients and healthcare providers.

Technological advancements in ablation systems are further supporting market expansion. Radiofrequency electrodes, thermal balloon systems, heated fluid technologies, microwave energy, and cryotherapy provide different approaches for controlled destruction of the endometrial lining. Radiofrequency systems, in particular, offer rapid treatment and consistent energy delivery. Clinical studies have also demonstrated favorable bleeding-control outcomes with bipolar radiofrequency ablation.

Growing awareness of alternatives to hysterectomy is creating additional opportunities for the market. Endometrial ablation provides a uterine-sparing treatment option for appropriately selected women with heavy menstrual bleeding. Increasing awareness among patients and healthcare professionals, along with improvements in outpatient gynecological care, is expected to support procedure adoption.

However, the market faces challenges such as the high cost of advanced ablation equipment, procedure eligibility limitations, and the availability of alternative treatments such as medication and hysterectomy. Despite these challenges, continued technological development, increasing demand for minimally invasive care, and rising healthcare investment are expected to create growth opportunities for the endometrial ablation market during the forecast period.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study provides key insights about market drivers, restraints, opportunities, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the Endometrial Ablation Market based on company highlights, product portfolio, key developments, financial performance, and strategies.
Key companies covered as part of this study include RF Medical, Erbe Inc., MedGyn Inc., Ri.Mos. Inc., Biosense Webster Inc., Hansen Medical Inc., Biotronik, Smith & Nephew plc, Arthrex, and Wallach.
Insights from this report would allow marketers and management authorities to make informed decisions regarding product development, market expansion, and strategic partnerships.
The Endometrial Ablation Market report caters to various stakeholders including endometrial ablation device manufacturers, gynecologists, hospitals, healthcare providers, distributors, investors, regulatory authorities, and industry analysts.
Stakeholders would benefit from structured analytical frameworks and strategy matrices used in evaluating the Endometrial Ablation Market.

Market Segmentation

By Device Type (Revenue, USD Bn, 2021-2033)
Resectoscope
Remote temperature probe
Radiofrequency electrodes
Others
By Ablation Method (Revenue, USD Bn, 2021-2033)
Thermal balloon ablation
Radiofrequency electrosurgery ablation
Circulated hot fluid ablation
Microwave energy ablation
Cryotherapy ablation
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Pharmaceutical companies
Clinical laboratories
By Region Insights (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players
RF Medical
Erbe Inc.
MedGyn Inc.
Ri.Mos. Inc.
Biosense Webster Inc.
Hansen Medical Inc.
Biotronik
Smith & Nephew plc
Arthrex
Wallach

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Device Type
- Market Snippet, By Ablation Method
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Recent Product Launches/Approvals
Regulatory Scenario
PEST Analysis
Acquisition and Collaboration Scenario

4. Global Endometrial Ablation Market, By Device Type, 2021 - 2033 (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Resectoscope
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Remote Temperature Probe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Radiofrequency Electrodes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Endometrial Ablation Market, By End User, 2021 - 2033 (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Clinical Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Endometrial Ablation Market, By Ablation Method, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Thermal Balloon Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Radiofrequency Electrosurgery Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Circulated Hot Fluid Ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Microwave energy ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Cryotherapy ablation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Global Endometrial Ablation Market, By Region, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2021 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By End User 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Ablation Method, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By End User 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Ablation Method, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By End User 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Ablation Method, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of APAC
Latin America
- Market Size and Forecast, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By End User 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Ablation Method, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By End User 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Ablation Method, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Device Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By End User 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Ablation Method, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Country, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- RF Medical
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Erbe Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- MedGyn Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Ri.Mos. Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Biosense Webster Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Hansen Medical Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Biotronik
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Smith & Nephew plc
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Arthrex
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates
- Wallach.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Key Strategies
  - Recent Developments/Updates